Medicine Matters rheumatology
Medicine Matters rheumatology is a resource for global and local audiences of healthcare professionals caring for patients with rheumatic diseases.Our objective is to provide information on the latest advances in rheumatic medicine, to promote good clinical practice and improve patient care.
Guided by our distinguished Editorial Board, Medicine Matters rheumatology will:
• Be a trusted online source of daily news and expert opinion
• Provide regularly updated, freely accessible peer-reviewed content from Springer Nature
• Deliver educational tools and continuing medical education (CME) to support professional development
• Summarize clinical content into formats appealing to a broad range of healthcare professionals
• Provide practical information and discussion for general practitioners and nurses around the management of rheumatic diseases
• Help allied professionals achieve their information needs in a time efficient manner
- 3:02
- 2 жыл бұрын
BE MOBILE 1 and 2: How might bimekizumab impact axSpA clinical practice? | Fabian Proft
- 3:19
- 2 жыл бұрын
BE COMPLETE and BE OPTIMAL: How might bimekizumab impact PsA clinical practice? | Philippe Carron
- 13:17
- 2 жыл бұрын
Rituximab use in the COVID-19 era: Striking the right balance | Sebastian Sattui and David Jayne
- 5:10
- 2 жыл бұрын
Risankizumab for PsA: How will the KEEPsAKE 1 & 2 findings impact clinical practice? | Laura ...
- 3:45
- 3 жыл бұрын
FDA approval of anifrolumab for SLE | Eric Morand
- 4:29
- 3 жыл бұрын
First COVAX Registry data on COVID-19 vaccine safety for patients with RMDs | Pedro Machado
- 7:11
- 3 жыл бұрын
RESOLVE-1 fails to meet primary endpoint for lenabasum in patients with dcSSc | Robert Spiera
- 10:49
- 3 жыл бұрын
Repurposing rheumatology drugs for COVID-19: JAK inhibitors
- 8:06
- 3 жыл бұрын
Study finds link between RA treatment and COVID-19 severity | Jeffrey Sparks and Zachary Wallace
- 1:40
- 3 жыл бұрын
Five things rheumatologists can do to improve their telemedicine practice | Aruni Jayatilleke
- 1:10
- 3 жыл бұрын
Three things rheumatologists can do to improve their telemedicine practice | Chris Phillips
- 5:16
- 3 жыл бұрын
ACR 2020 | Denis Poddubnyy discusses the SKIPPAIN trial
- 4:47
- 3 жыл бұрын
ACR 2020 | Richard Furie discusses the LILAC trial
- 4:25
- 3 жыл бұрын
ACR 2020 | Marina Magrey comments on a phase 3 trial of tofacitinib in ankylosing spondylitis
- 6:25
- 3 жыл бұрын
Пікірлер